Results
1
-
10
of
123
<
1
2
3
...
12
13
>
[DOI: 10.1021/ml200268w]
G?lvez R; Sch?fer M; Hans G; Falke D; Steigerwald I.
Tapentadol prolonged release versus strong opioids for severe, chronic low back pain: results of an open-label, phase 3b study.
,
Advances in therapy
[DOI: 10.1007/s12325-013-0015-6]
Moyo J; Rashiq S.
Perioperative considerations for "new" kids on the opioid block.
,
Canadian journal of anaesthesia = Journal canadien d'anesthesie
[DOI: 10.1007/s12630-011-9476-8]
Miotic and subject-rated effects of therapeutic doses of tapentadol, tramadol, and hydromorphone in occasional opioid users.
,
Psychopharmacology
[DOI: 10.1007/s00213-013-3031-y]
Combatting pain after orthopedic/trauma surgery- perioperative oral extended-release tapentadol vs. extended-release oxycodone/naloxone.
,
BMC Anesthesiology
[DOI: 10.1186/s12871-017-0383-6]
[Dual effect prevents chronic course].
,
MMW - Fortschritte der Medizin
[DOI: 10.1007/s15006-015-7639-1]
Safety and tolerability of tapentadol extended release in moderate to severe chronic osteoarthritis or low back pain management: pooled analysis of randomized controlled trials.
,
Advances in Therapy
[DOI: 10.1007/s12325-014-0128-6]
Pharmacokinetic and pharmacodynamic modeling of opioid-induced gastrointestinal side effects in patients receiving tapentadol IR and oxycodone IR.
,
Pharmaceutical Research
[DOI: 10.1007/s11095-012-0786-5]
[Undesired side effects of tapentadol in comparison to oxycodone. A meta-analysis of randomized controlled comparative studies].
,
Der Schmerz
[DOI: 10.1007/s00482-011-1132-2]
Comparable efficacy and superior gastrointestinal tolerability (nausea, vomiting, constipation) of tapentadol compared with oxycodone hydrochloride.
,
Advances in Therapy
[DOI: 10.1007/s12325-011-0018-0]
<
1
2
3
...
12
13
>